Ads
related to: intuitive surgical nasdaq
Search results
HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom
InvestorPlace via Yahoo Finance· 7 days agoWhile the biotechnology sector may receive most of the attention under the broad healthcare...
Retirement Stocks to Buy: 7 Picks Offering Value, Growth, and Dividends
InvestorPlace· 6 days agoFinding the best retirement stocks that perfectly align with every investor’s portfolio is...
HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom
InvestorPlace· 7 days agoWith innovations constantly being developed in the healthcare space, investors should target these...
FluoGuide A/S Publishes Interim Report for the Period January - March 2024
Morningstar· 5 days agoKØBENHAVN, DK / ACCESSWIRE / May 30, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 30 May 2024 - FluoGuide A/S ("FluoGuide" or the "Company") today releases its results for the period 1 January - 31 March 2024. The Q1 report is available as an
What I’m Telling My Clients About Investing in AI
Investopedia· 1 day agoHere's what Marguerita Cheng, certified financial planner and CEO of Blue Ocean Global Wealth, is telling her clients about investing in artificial intelligence (AI).
FluoGuide A/S Publishes Interim Report for the Period January
Digital Journal· 5 days agoIt is anticipated that FG001 will decrease both the incidence of local recurrence after surgery and surgical complications, improving cancer treatment and outcomes for patients ...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 5 days agoSummit (Nasdaq: SMMT) — led by the team that scored success with blood cancer drug developer...
Artificial Intelligence ETFs: Have They Beaten The Market In 2024? - Autodesk (NASDAQ:ADSK), ABB...
Benzinga· 6 days agoAI ETFs like BOTZ, AIQ, and ROBO have performed well in 2024 but couldn't beat the S&P 500, driven...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoSOLANA BEACH, Calif., June 01, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering ...
